Rescue of TRAF3-null mice by p100 NF-κB deficiency

被引:137
作者
He, Jeannie Q.
Zarnegar, Brian
Oganesyan, Gagik
Saha, Supriya K.
Yamazaki, Soh
Doyle, Sean E.
Dempsey, Paul W.
Cheng, Genhong [1 ]
机构
[1] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Med Sci Training Program, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA
关键词
D O I
10.1084/jem.20061166
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Proper activation of nuclear factor (NF)-kappa B transcription factors is critical in regulating fundamental biological processes such as cell survival and proliferation, as well as in inflammatory and immune responses. Recently, the NF-kappa B signaling pathways have been categorized into the canonical pathway, which results in the nuclear translocation of NF-kappa B complexes containing p50, and the noncanonical pathway, which involves the induced processing of p100 to p52 and the formation of NF-kappa B complexes containing p52 (Bonizzi, G., and M. Karin. 2004. Trends Immunol. 25:280-288). We demonstrate that loss of tumor necrosis factor (TNF) receptor-associated factor 3 (TRAF3) results in constitutive noncanonical NF-kappa B activity. Importantly, TRAF3(-/-) B cells show ligand-independent up-regulation of intracellular adhesion molecule 1 and protection from spontaneous apoptosis during in vitro culture. In addition, we demonstrate that loss of TRAF3 results in profound accumulation of NF-kappa B-inducing kinase in TRAF3(-/-) cells. Finally, we show that the early postnatal lethality observed in TRAF3-deficient mice is rescued by compound loss of the noncanonical NF-kappa B p100 gene. Thus, these genetic data clearly demonstrate that TRAF3 is a critical negative modulator of the noncanonical NF-kappa B pathway and that constitutive activation of the noncanonical NF-kappa B pathway causes the lethal phenotype of TRAF3-deficient mice.
引用
收藏
页码:2413 / 2418
页数:6
相关论文
共 30 条
[1]  
BARRETT TB, 1991, J IMMUNOL, V146, P1722
[2]   The two NF-κB activation pathways and their role in innate and adaptive immunity [J].
Bonizzi, G ;
Karin, M .
TRENDS IN IMMUNOLOGY, 2004, 25 (06) :280-288
[3]   Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses [J].
Caamaño, JH ;
Rizzo, CA ;
Durham, SK ;
Barton, DS ;
Raventós-Suárez, C ;
Snapper, CM ;
Bravo, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (02) :185-196
[4]   BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells [J].
Claudio, E ;
Brown, K ;
Park, S ;
Wang, HS ;
Siebenlist, U .
NATURE IMMUNOLOGY, 2002, 3 (10) :958-965
[5]   CD40 regulates the processing of NF-κB2 p100 to p52 [J].
Coope, HJ ;
Atkinson, PGP ;
Huhse, B ;
Belich, M ;
Janzen, J ;
Holman, MJ ;
Klaus, GGB ;
Johnston, LH ;
Ley, SC .
EMBO JOURNAL, 2002, 21 (20) :5375-5385
[6]   The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways [J].
Dejardin, E ;
Droin, NM ;
Delhase, M ;
Haas, E ;
Cao, YX ;
Makris, C ;
Li, ZW ;
Karin, M ;
Ware, CF ;
Green, DR .
IMMUNITY, 2002, 17 (04) :525-535
[7]   The signaling adaptors and pathways activated by TNF superfamily [J].
Dempsey, PW ;
Doyle, SE ;
He, JQ ;
Cheng, GH .
CYTOKINE & GROWTH FACTOR REVIEWS, 2003, 14 (3-4) :193-209
[8]   Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain [J].
Deng, L ;
Wang, C ;
Spencer, E ;
Yang, LY ;
Braun, A ;
You, JX ;
Slaughter, C ;
Pickart, C ;
Chen, ZJ .
CELL, 2000, 103 (02) :351-361
[9]  
FRACCHIOLLA NS, 1993, ONCOGENE, V8, P2839
[10]   TRAF2 differentially regulates the canonical and noncanonical pathways of NF-κB activation in mature B cells [J].
Grech, AP ;
Amesbury, M ;
Chan, T ;
Gardam, S ;
Basten, A ;
Brink, R .
IMMUNITY, 2004, 21 (05) :629-642